Chemotherapy of neuroblastoma.
D000367:Age Factors; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D066298:In Vitro Techniques; D007223:Infant; D051379:Mice; D009447:Neuroblastoma / Q000188:drug therapy*; D010208:Papaverine / Q000627:therapeutic use; D012673:Semustine / Q000627:therapeutic use; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D012673:Semustine; D003609:Dactinomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D010208:Papaverine; D003630:Daunorubicin